As the contract negotiations have been pushed forward due to a heavy workload with focus on the commercialization in Qatar, the Annual General Meeting and the ongoing subscription period, Lissner will remain as acting CEO until the contract as permanent CEO is signed.

"This delay is only a matter of time management and prioritizations. Our discussions and negotiations are very positive, and we look forward to extending the contract with Erik as permanent CEO. I feel very confident that he and the team at Brighter will continue to run the company towards new upcoming milestones in both Qatar and other key markets." says Christer Trägårdh, Chairman of the Board of Brighter AB.

For further information, please contact:
Investor Relations
ir@brighter.se

Certified Adviser
Brighter's Certified Adviser är Mangold Fondkommission AB,
+46 8 5277 5020, ca@mangold.se, www.mangold.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones, and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at https://brighter.se/.